PDCD1LG2 and cancer: Cancer cells can generate an immunosuppressive tumor microenvironment by expressing high amounts of inhibitory ligands such as PD-L1 and PD-L2, inhibiting the responses of T lymphocytes by binding to the PD-1 inhibitory receptor expressed by T lymphocytes, avoiding cytolysis by activated T cells towards cancer cells.